Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study.
Humans
Metapneumovirus
/ genetics
Respiratory Syncytial Virus Infections
/ epidemiology
Infant
Female
Male
Child, Preschool
Paramyxoviridae Infections
/ epidemiology
Retrospective Studies
China
/ epidemiology
Child
COVID-19
/ epidemiology
Respiratory Syncytial Virus, Human
/ genetics
Prevalence
Risk Factors
SARS-CoV-2
/ genetics
Respiratory Tract Infections
/ epidemiology
Adolescent
Seasons
Infant, Newborn
Incidence
Severity of Illness Index
acute respiratory tract illness
human metapneumovirus
intensive care
pediatric
respiratory syncytial virus
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2024
2024
Historique:
received:
20
05
2024
accepted:
07
08
2024
medline:
17
9
2024
pubmed:
17
9
2024
entrez:
17
9
2024
Statut:
epublish
Résumé
We aim to investigate the prevalence of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) among pediatric patients with acute respiratory tract illness (ARTI) in southern China both pre- and post-COVID-19 pandemic, as well as identify associated risk factors for severe infections. The study conducted a real-time PCR analysis on hospitalized children with ARTI from 2012 to 2023, specifically targeting RSV, hMPV, and other respiratory pathogens. Additionally, demographic data was collected during this analysis. The prevalence of RSV occurs triennially, and likewise, the temporal pattern of hMPV outbreaks mirrors that of RSV. The peak infection rates of RSV and hMPV occurred during and following the implementation of COVID-19 epidemic prevention and control measures. The incidence of RSV infection exhibited bimodal peaks in 2022, while hMPV demonstrated seasonal peaks during the spring, fall, and winter periods post-COVID-19 pandemic. After the COVID-19 outbreak, there has been an upward trend in the proportion of female patients and patients aged one year and older presenting with ARTI, RSV infections, and hMPV infections. Infant (OR = 4.767, 95%CI: [3.888-5.846], The changing epidemiological patterns have the potential to lead to widespread severe outbreaks among children, particularly those with underlying medical conditions who may experience more severe symptoms. Conducting surveillance for
Identifiants
pubmed: 39286815
doi: 10.3389/fcimb.2024.1435294
pmc: PMC11404324
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1435294Informations de copyright
Copyright © 2024 Kuang, Xu, Wang, Xie, Zhang, Guo, Liang and Zhu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
JAMA Netw Open. 2022 Jul 1;5(7):e2220949
pubmed: 35816304
Lancet Glob Health. 2021 Jan;9(1):e33-e43
pubmed: 33248481
Clin Infect Dis. 2021 Jun 15;72(12):2199-2202
pubmed: 32986804
Pediatr Infect Dis J. 2013 Aug;32(8):911-4
pubmed: 23429553
MMWR Morb Mortal Wkly Rep. 2023 Apr 07;72(14):355-361
pubmed: 37022977
J Med Virol. 2023 Jul;95(7):e28928
pubmed: 37455559
Emerg Infect Dis. 2022 Jan;28(1):62-68
pubmed: 34932446
J Infect Dis. 2005 Feb 1;191(3):382-6
pubmed: 15633097
J Infect Dis. 2018 Apr 11;217(9):1356-1364
pubmed: 29390105
J Infect Dis. 2002 Nov 1;186(9):1330-4
pubmed: 12402203
BMJ. 2019 Sep 10;366:l5021
pubmed: 31506273
Lancet. 2022 May 28;399(10340):2047-2064
pubmed: 35598608
Euro Surveill. 2022 May;27(19):
pubmed: 35551702
Pediatr Infect Dis J. 2023 Nov 1;42(11):960-964
pubmed: 37523504
Pediatrics. 2016 May;137(5):
pubmed: 27244790
Nat Rev Microbiol. 2023 Mar;21(3):195-210
pubmed: 36253478
Lancet. 2024 Mar 30;403(10433):1241-1253
pubmed: 38367641
J Gen Virol. 2017 Dec;98(12):2912-2913
pubmed: 29087278
PLoS One. 2023 Feb 16;18(2):e0281555
pubmed: 36795639
Eur Respir J. 2008 Aug;32(2):314-20
pubmed: 18448489
Am J Dis Child. 1986 Jun;140(6):543-6
pubmed: 3706232
J Med Virol. 2022 Dec;94(12):5894-5903
pubmed: 35981880
J Infect Dis. 2004 Jul 1;190(1):20-6
pubmed: 15195239
J Infect. 2022 May;84(5):722-746
pubmed: 35123959
MMWR Morb Mortal Wkly Rep. 2022 Oct 07;71(40):1253-1259
pubmed: 36201373
Nat Med. 2001 Jun;7(6):719-24
pubmed: 11385510
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
N Engl J Med. 2009 Feb 5;360(6):588-98
pubmed: 19196675
J Med Virol. 2008 Apr;80(4):716-23
pubmed: 18297694